Regeneron Pharmaceuticals
The company is seeking a Senior Associate Scientist for its Oncology & Immuno-Oncology group to advance next-generation bispecific antibody therapeutics for solid tumors. This role involves leading in vivo and ex vivo experimental studies, processing tumor tissues, and collaborating with cross-functional teams to drive programs from preclinical development toward clinical application. The ideal candidate thrives in a fast-paced translational research environment and possesses strong skills in immune profiling and data interpretation.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
23% below the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Associate Director, Immuno-Oncology Research
Moderna
Senior Scientist II/Associate Principal Scientist, Pharmacology
American Association of Physicists in Medicine
Principal Scientist
Syngene International Limited
In Vivo Pharmacology Sr. Associate Scientist
Pfizer
Senior Scientist, Immuno-Oncology
Systimmune
Senior Research Associate
Integrated Resources INC